Investors
Investing in the next generation of insulin delivery.
Pocket Clinic is developing a wearable, rechargeable 7-day smart injector designed to make insulin delivery simpler, more affordable and accessible. We welcome conversations with investors and strategic partners who share our goal of advancing diabetes care.
Progress to Date
Key technical and regulatory milestones are already behind us.
Next: design freeze, design verification and validation, and preparation for an FDA 510(k) submission.
The Opportunity
Millions of patients are candidates for automated delivery, yet still inject insulin by hand.
adults living with diabetes worldwide
people worldwide rely on insulin
pump-eligible Americans still manage insulin with multiple daily injections
Sources: IDF Diabetes Atlas, 11th ed. (2024–25); CDC National Diabetes Statistics Report (2023 data); Pocket Clinic analysis.
Why Now
Three converging trends make a wearable, 7-day smart injector possible.
Continuous monitoring is mainstream
Leading glucose monitors now reach more than 10 million users, and recent over-the-counter approvals have broadened access to real-time data.
Micro-actuators are medical-grade
MEMS actuators have crossed the cost and reliability threshold for disposable medical use, enabling small, precise dosing.
Injectables are normal
GLP-1 therapies have normalized self-injection and reset patient expectations, and the same delivery infrastructure extends to insulin.
Our Approach
Capacity, stability and longevity, all in one device.
Today, no single option addresses drug capacity, stability and longevity together. The 7-Day Smart Injector is designed to bring them into one wearable, with fewer disposables and a lower cost to patients.
Wearable
Seven days of continuous delivery from one device.
Interchangeable
Cartridges up to 5 ml for personalized delivery.
Rechargeable
A 7-day battery lifecycle, recharged rather than thrown away.
Thermostable
Designed for 7-day insulin stability.
Leadership
An experienced team of engineers, clinicians and industry leaders.
Amir Omidvar, PhD
CEO, Co-Founder
Atena Amanati, PhD
CTO, Co-Founder
Marcia Queiroz, MD
Chief Medical Officer
Naghmeh Nouri
Chief Regulatory & Quality Officer
Alejandro Vivanco
Chief Financial Officer
Supported by senior advisors with global experience across pharmaceuticals, medical devices, regulatory affairs and business development, and proven track records of success. Meet the full team and advisors →
Start a Conversation
Interested in partnering with Pocket Clinic?
Our investor materials, including our development plan and financing details, are available to qualified investors upon request.
This page contains forward-looking statements about product development and regulatory plans. Actual results may differ. This page is not an offer to sell or a solicitation to buy securities.